ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,567.19
      1.06%
      US Tech 100
      19,828.00
      0.95%
      Dow Jones
      39,375.87
      0.17%
      Brent Oil
      86.775
      0.00%
      Bitcoin
      56,539.49
      -0.19%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. InMed Pharmaceuticals Inc (INM)

      7. InMed Pharmaceuticals Inc (INM) News

      INM

      InMed Pharmaceuticals (INM)

      InMed Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:INM
      DateTimeSourceHeadlineSymbolCompany
      10/19/20226:04AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:INMInMed Pharmaceuticals Inc
      10/12/20226:02AMEdgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:INMInMed Pharmaceuticals Inc
      09/29/20221:53PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INMInMed Pharmaceuticals Inc
      09/23/20223:35PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:INMInMed Pharmaceuticals Inc
      09/23/202212:39PMTipRanksInMed Pharmaceuticals reports FY22 EPS ($33.17) vs. ($37.96) last yearNASDAQ:INMInMed Pharmaceuticals Inc
      09/23/202212:29PMGlobeNewswire Inc.InMed Pharmaceuticals Reports Full Year Fiscal 2022 Financial Results and Provides Business UpdateNASDAQ:INMInMed Pharmaceuticals Inc
      09/20/20229:19AMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:INMInMed Pharmaceuticals Inc
      09/20/20229:17AMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:INMInMed Pharmaceuticals Inc
      09/20/20229:16AMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:INMInMed Pharmaceuticals Inc
      09/20/20229:15AMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:INMInMed Pharmaceuticals Inc
      09/20/20229:14AMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:INMInMed Pharmaceuticals Inc
      09/20/20229:14AMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:INMInMed Pharmaceuticals Inc
      09/20/20229:11AMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:INMInMed Pharmaceuticals Inc
      09/19/20226:00PMGlobeNewswire Inc.InMed Pharmaceuticals to Report Full Year Fiscal 2022 Financial Results and Business Update on September 23, 2022NASDAQ:INMInMed Pharmaceuticals Inc
      09/14/20226:03AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INMInMed Pharmaceuticals Inc
      09/13/20225:12PMGlobeNewswire Inc.InMed Pharmaceuticals Announces Closing of $6 Million Private Placement Priced at a Premium to MarketNASDAQ:INMInMed Pharmaceuticals Inc
      09/09/20225:00PMGlobeNewswire Inc.InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to MarketNASDAQ:INMInMed Pharmaceuticals Inc
      09/09/20229:16AMTipRanksInMed (NASDAQ: INM) Shoots Up As It Shifts Focus to its Core BusinessNASDAQ:INMInMed Pharmaceuticals Inc
      09/08/20222:08PMGlobeNewswire Inc.InMed Pharmaceuticals Provides Update on its Core Research and Development Programs and BayMedica BusinessNASDAQ:INMInMed Pharmaceuticals Inc
      08/23/20225:00PMGlobeNewswire Inc.InMed Announces Share Consolidation to Meet Nasdaq Listing CriteriaNASDAQ:INMInMed Pharmaceuticals Inc
      08/09/20227:30AMGlobeNewswire Inc.InMed Announces Changes to its Board of DirectorsNASDAQ:INMInMed Pharmaceuticals Inc
      07/26/20221:33PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INMInMed Pharmaceuticals Inc
      07/25/20227:30AMGlobeNewswire Inc.InMed Announces Update on Phase 2 Clinical Trial Investigating INM-755 Cannabinol Cream for Epidermolysis BullosaNASDAQ:INMInMed Pharmaceuticals Inc
      07/20/20226:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INMInMed Pharmaceuticals Inc
      07/18/20227:30AMGlobeNewswire Inc.InMed Announces Appointment of Chief Operating OfficerNASDAQ:INMInMed Pharmaceuticals Inc
      07/18/20226:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INMInMed Pharmaceuticals Inc
      07/12/202211:33PMGlobeNewswire Inc.InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price ComplianceNASDAQ:INMInMed Pharmaceuticals Inc
      07/06/20222:44PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:INMInMed Pharmaceuticals Inc
      06/30/20226:06AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:INMInMed Pharmaceuticals Inc
      06/24/20225:23PMEdgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:INMInMed Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:INM

      Your Recent History

      BIT
      PSA
      Portale Sardegna S.p.A
      Delayed Upgrade Clock